Open AccessPeer review of the pesticide risk assessment of the active substance Purpureocillium lilacinum strain 251
Author(s) -
Anastassiadou Maria,
Arena Maria,
Auteri Domenica,
Brancato Alba,
Bura Laszlo,
Carrasco Cabrera Luis,
Chaideftou Eugenia,
Chiusolo Arianna,
Crivellente Federica,
De Lentdecker Chloe,
Egsmose Mark,
Fait Gabriella,
Greco Luna,
Ippolito Alessio,
Istace Frederique,
Jarrah Samira,
Kardassi Dimitra,
Leuschner Renata,
Lostia Alfonso,
Lythgo Christopher,
Magrans Oriol,
Mangas Iris,
Miron Ileana,
Molnar Tunde,
Padovani Laura,
Parra Morte Juan Manuel,
Pedersen Ragnor,
Reich Hermine,
Santos Miguel,
Sharp Rachel,
Szentes Csaba,
Terron Andrea,
Tiramani Manuela,
Vagenende Benedicte,
VillamarBouza Laura
Publication year - 2020
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2020.6238
Subject(s) - context (archaeology) , european commission , strain (injury) , european union , pesticide , risk assessment , biology , business , agronomy , international trade , computer security , computer science , paleontology , anatomy
The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State, Hungary, and co‐rapporteur Member State, the Netherlands, for the pesticide active substance Purpureocillium lilacinum strain 251, formerly called Paecilomyces lilacinus strain 251, are reported. The context of the peer review was that required by Commission Implementing Regulation ( EU ) No 844/2012, as amended by Commission Implementing Regulation ( EU ) No 2018/1659. The conclusions were reached on the basis of the evaluation of the representative uses of Purpureocillium lilacinum strain 251 as a biological nematicide on tomato and cucumber (uses in the field and permanent greenhouses). The reliable end points, appropriate for use in regulatory risk assessment, are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are identified.